Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 5Neoplasm Metastasis 2Lung Neoplasms 2Brain Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Precancerous Conditions 1Pleural Effusion, Malignant 1Osteoporosis 1Neoplasms 1Lymphatic Metastasis 1Kidney Neoplasms 1Gliosarcoma 1Glioblastoma 1Cervical Neoplasia 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 131Radiotherapy 87Bevacizumab 43Radiation 31Carmustine 29Magnetic Resonance Spectroscopy 22Irinotecan 22Erlotinib Hydrochloride 22Chemotherapy, Adjuvant 20Surgical Procedures, Operative 15O(6)-benzylguanine 15Carboplatin 14Radiotherapy, Intensity-Modulated 13Radiotherapy, Conformal 13sargramostim 12Sirolimus 9Imatinib Mesylate 9Filgrastim 9Drug Therapy 9temsirolimus 8Thalidomide 8Sorafenib 8Radiosurgery 8pembrolizumab 7motexafin gadolinium 7aldesleukin 7Vorinostat 7Procarbazine 7Gene Expression Profiling 7Gefitinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Spectrum Analysis × Clear all
NCT00004262 2013-06-04

Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡